What is the official ID of this bill?
The official print number for this legislation is HR 133.
Medicare: Individual Drug Review, Not Class-Based Assessments
New Medicare rules change how drugs are evaluated. Instead of assessing entire drug classes, each drug will now be individually reviewed for its necessity and reasonableness. This aims to ensure that coverage decisions are more precise and tailored to specific products, potentially affecting drug availability and costs for patients.
Key points
Each drug will be individually assessed by Medicare, not as part of a larger group.
The change aims for more precise determination of whether a drug is necessary and justified.
This may impact which drugs are covered by Medicare and under what conditions.
Status:
Expired
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens
(explained here).
Start recording it now.